Project/Area Number |
04670995
|
Research Category |
Grant-in-Aid for General Scientific Research (C)
|
Allocation Type | Single-year Grants |
Research Field |
Obstetrics and gynecology
|
Research Institution | GIFU UNIVERSITY |
Principal Investigator |
NIWA Kenji (1994) Gifu Univ, School of Medicine, Research Associate, 医学部・附属病院, 助手 (80218247)
森 秀弘 (1992-1993) 岐阜大学, 医学部・附属病院, 講師 (50190997)
|
Co-Investigator(Kenkyū-buntansha) |
TAMAYA Teruhiko Gifu Univ, School of Medicine, Professor, 医学部, 教授 (70079870)
MISAO Ryo Gifu Univ, School of Medicine, Research Associate, 医学部・附属病院, 助手 (40262761)
丹羽 憲司 岐阜大学, 医学部・附属病院, 助手 (80218247)
|
Project Period (FY) |
1992 – 1994
|
Project Status |
Completed (Fiscal Year 1994)
|
Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1993: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1992: ¥600,000 (Direct Cost: ¥600,000)
|
Keywords | DNA topoisomerase I / mRNA / RT-PCR / Cancer cell lines / Camptothecin / Cytokines / anti-proliferative activity / Chemotherapy / DNA topoisomerase / camptotecin / CPT-11 / cell lines / ギャップ・ジャンクション / paclitaxel / コネキシン43 / 化学療法 / 婦人科癌 |
Research Abstract |
1. The anti-proliferative effects of INF-gamma and CPT-11, a new derivative of camptothecin, on two human endometrial cancer cell lines were examined in vitro. In both cell lines, INF-gamma enhanced the anti-proliferative activity of CPT-11. 2. Expression of DNA topoisomerase (Topo) -I mRNA in various cancer cell lines was detected using reverse transcription-polymerase chain reaction (RT-PCR) method. The cytoplasmic polyadenylated RNA isolated from cancer cell lines was reverse-transcribed and the complementary DNA was amplified by PCR primed with Topo-I specific primers. The level of Topo-I mRNA was correlated positively with the cytotoxicity of a Topo-I inhibitor. 3.The combination therapy of CPT-11 and INF-gamma will be examined in tumor-bearing mice or rats.
|